Hospital Oncologico, Puerto Rico Medical Center

Rio Piedras 935

2 studies enrolling now · 3 studies all time

What they study most

Advanced Cholangiocarcinoma, Biliary Tract Cancer, FGFR2 Gene Mutation, Familial Adenomatous Polyposis (FAP)

Studies at this site

• Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer — Recruiting now
• Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis — Recruiting now
• Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations — Stopped early